These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22666141)

  • 41. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
    Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
    Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
    Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
    Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune modulation and chronic graft-versus-host disease.
    Soiffer R
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S66-S69. PubMed ID: 18724307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
    Schneider M; Munder M; Karakhanova S; Ho AD; Goerner M
    Clin Lab Haematol; 2006 Dec; 28(6):382-90. PubMed ID: 17105491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation.
    Arimoto K; Kadowaki N; Ishikawa T; Ichinohe T; Uchiyama T
    Int J Hematol; 2007 Feb; 85(2):154-62. PubMed ID: 17321995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance of CD8+ T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease.
    Kim J; Kim HJ; Choi WS; Nam SH; Cho HR; Kwon B
    Exp Mol Med; 2006 Oct; 38(5):494-501. PubMed ID: 17079865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Reconstitution kinetics of T helper cells subsets post unmanipulated allogeneic blood and marrow transplantation].
    Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):745-50. PubMed ID: 24103870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [CD200/CD200R Expression Levels and Its Significance after Allogeneic Hematopoietic Stem Cell Transplantation].
    Huang YH; Zhang W; Cai H; Li TJ; Li J; Han B; Zhuang JL; Zhu TN; Cai HC; Zhou DB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):815-20. PubMed ID: 27342516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions.
    Pietruczuk M; Eusebio M; Kraszula L; Kupczyk M; Kuna P
    J Biol Regul Homeost Agents; 2012; 26(4):627-39. PubMed ID: 23241113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients.
    Roschupkina T; Juliusson G
    Cytometry B Clin Cytom; 2018 Mar; 94(2):264-269. PubMed ID: 27479496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD.
    Fujioka T; Tamaki H; Ikegame K; Yoshihara S; Taniguchi K; Kaida K; Kato R; Inoue T; Nakata J; Ishii S; Soma T; Okada M; Ogawa H
    Bone Marrow Transplant; 2013 Jun; 48(6):859-64. PubMed ID: 23165499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.
    Zorn E; Mohseni M; Kim H; Porcheray F; Lynch A; Bellucci R; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):382-8. PubMed ID: 19203731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR; Mayani H
    Ann Hematol; 2006 Feb; 85(2):113-20. PubMed ID: 16311734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.
    Hu R; Liu Y; Su M; Song Y; Rood D; Lai L
    Stem Cells Transl Med; 2017 Jan; 6(1):121-130. PubMed ID: 28170174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
    Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
    Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
    Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
    Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
    Ding L; Zhu H; Yang Y; Yan HM; Zhang HH; Han DM; Wang ZD; Zheng XL; Liu J; Zhu L; Mei-Xue ; Guo ZK; Wang HX
    Leuk Res; 2017 May; 56():13-20. PubMed ID: 28161606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The Role and Mechanism of Tfh and B Cell in Human Chronic Graft-Versus-Host-Disease].
    Lyu KK; Xu MM; DU YY; He XF; Chen F; Ma X; Han Y; Wu DP; Liu YJ; Xu MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):593-599. PubMed ID: 35396002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD.
    Leveque-El Mouttie L; Koyama M; Le Texier L; Markey KA; Cheong M; Kuns RD; Lineburg KE; Teal BE; Alexander KA; Clouston AD; Blazar BR; Hill GR; MacDonald KP
    Blood; 2016 Aug; 128(6):794-804. PubMed ID: 27338097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.